Novartis Investigative Site

Jasper, Alabama 35501

0 studies enrolling now · 7 studies all time

What they study most

COPD, Chronic Obstructive Pulmonary Disease, Obesity, Overweight

Studies at this site

• A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults — Completed
• Efficacy and Safety Study of QVA149 in COPD Patients — Completed
• NVA237 Versus Placebo 12-week Efficacy Study — Completed
• Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations — Completed
• Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks — Completed
• Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed